Lexicon Pharmaceuticals Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
105.88 M |
Public Float |
22.55 M |
Lexicon Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.95 |
Market Cap |
$668.45 M |
Shares Outstanding |
106.27 M |
Public Float |
102.99 M |
Address |
8800 Technology Forest Place The Woodlands Texas 77381 United States |
Employees | - |
Website | http://www.lexpharma.com |
Updated | 07/08/2019 |
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. It also offers programs in clinical development for diabetes, irritable bowel syndrome, and carcinoid syndrome. The company was founded by Brian P. |